Release Date: 28/02/18 16:54 Summary: 2017 Full Year Accounts and Annual Report Price Sensitive: No Download Document 447.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%